The Motor Accident Insurance Commission of Queensland (MAIC) has again extended the support of the Spinal Injury Project team at Griffith University. With this strong support, the team will continue to improve the olfactory cell transplantation therapy for spinal cord injury, and will also expand the therapy to treat peripheral nerve and brain injuries.
For the first part of this funding period, the research team will be mainly focused on generating more information about the olfactory nerve bridges for treating spinal cord injury. This will allow any improvements to be rapidly incorporated into the upcoming Phase I/IIA clinical trial.
Apart from the exciting laboratory research that is creating world-first therapies, the research team will increase their community and industry engagement to ensure that the therapies are what the public want and that industry is able to eventually help commercialise the therapy.
